Results 161 to 170 of about 53,817 (192)

Development of gemcitabine-modified multimodal miR-129 mimic as a novel therapeutic in non-small cell lung cancer. [PDF]

Mol Ther Nucleic Acids
Intriago EM, Pal A, Ojha A, Cui M, Pesselev IY, Coant N, Guo I, Haley J, Ju J.   +8 more
europepmc   +1 more source

DISCERN: inferring drug sensitivity from single-cell transcriptomes using cell-type-specific genetic interaction networks. [PDF]

Genome Med
Liu M, Tian Y, Jia Y, Zhang J, Yi X, Sang S, Zhang N, Liu K, Peng Y, Wang Y, Li X, Chen B, Liang H, Gu Y.   +13 more
europepmc   +1 more source

Type II Minocycline-Induced Hyperpigmentation During Long-Term Management of an Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Acneiform Eruption. [PDF]

Cureus
Dunbar D, Hwang J, Driscoll M.
europepmc   +1 more source

AXL phosphosite mapping links FAK1 and YAP1 signaling to erlotinib resistance in EGFR-mutant lung cancer. [PDF]

Cell Rep
Creixell M, Taylor SD, Gerritsen J, Jiang M, Bae SY, Augustin T, Loui M, Boixo C, Minamino S, Gong V, Creixell P, White FM, Meyer AS.   +12 more
europepmc   +1 more source

Generative AI-Based Drug Design: Target-Aware Molecular Generation for EGFR Type I Inhibitors with Multiplatform Docking Validation. [PDF]

ACS Omega
Khan T, Kwak YB, Kim HC.
europepmc   +1 more source

Establishment and functional characterization of an EGFR-amplified tumoroid from squamous cell carcinoma of unknown primary. [PDF]

Hum Cell
Iwai M, Yokota E, Yukawa T, Matsumoto K, Urano T, Nakashima K, Doihara H, Takigawa N, Fujiwara H, Akiyama T, Haisa M, Naomoto Y, Fukazawa T, Yamatsuji T.   +13 more
europepmc   +1 more source

Design, synthesis, and anticancer evaluation of novel pyrrole-pyrazoline/chalcone hybrids: <i>in vitro</i> and computational insights into EGFR inhibition. [PDF]

RSC Med Chem
Alturki MS, Ahmed MF, Al Khzem AH, Gomaa MS, Sarafroz M, Tawfeeq N, Alharbi MM, Al Mouslem AK, Aldawsari MF, Alruwili WR, Khan SA, El-Haggar R, Almalki AH.   +12 more
europepmc   +1 more source

Targeting pancreatic cancer with combined inhibition of EGFR and RAF. [PDF]

PLoS One
Brandstetter J, Goldstein L, Schreiber T, Palme R, Lindner T, Joksch M, Krause B, Vollmar B, Kumstel S.   +8 more
europepmc   +1 more source

Eu(III), Tb(III), and Gd(III) Complexes With Dual Ligand Architecture: Synthesis, Characterization, Photoluminescence, Cytotoxic, and Molecular Docking Studies. [PDF]

Chem Biodivers
Sarıoğlu AO, Sogukomerogullari HG, Muhammed MT, Mısır BA, Akkoç S.   +4 more
europepmc   +1 more source

Association of erlotinib and acitretin for the treatment of Olmsted syndrome with erythromelalgia in a pediatric patient. [PDF]

An Bras Dermatol
Azulay-Abulafia L, Rodrigues Fagundes J, Ollague Cordova EE, Diniz Pacheco K, Hovnanian A.   +4 more
europepmc   +1 more source